A Phase II Trial of Telisotuzumab Vedotin With Osimertinib for EGFR Mutated NSCLC With c-MET Overexpression That is Progressing on Osimertinib
NCT07323641 · RECRUITING · Phase 2
There are 6 Phase 2 clinical trials for Lung Non Small Cell Carcinoma tracked on ReadTheTrial. This represents 50% of all 12 Lung Non Small Cell Carcinoma trials.
Phase 2 trials for Lung Non Small Cell Carcinoma represent a promising mid-stage segment of the research pipeline. Currently, 2 of these trials are actively recruiting participants.
Phase 2 trials for Lung Non Small Cell Carcinoma are clinical studies at this specific development stage. There are currently 6 such trials tracked on ReadTheTrial.
Review the individual trial pages for eligibility criteria and recruiting status. Currently 2 Phase 2 Lung Non Small Cell Carcinoma trials are recruiting. Discuss participation with your doctor.
Multiple organizations sponsor these trials.